Approved indications

• Control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis.
• Treatment of iron deficiency anemia in adult patients with CKD who are not on dialysis.

Off-label uses and evidence

• Studied in adults with non–dialysis-dependent CKD for combined management of iron deficiency anemia and elevated phosphate; trials show improved iron indices, hemoglobin, and lower phosphate, but this use is not FDA-approved.
• Clinicians may consider it when both phosphate control and iron repletion are desired, typically guided by nephrology or hematology specialists.

Efficacy expectations

• For high phosphorus in CKD on dialysis, blood phosphorus levels often begin to fall within 1–2 weeks, with full effect over several weeks as the dose is adjusted.
• For iron deficiency anemia in CKD not on dialysis, iron stores and hemoglobin usually improve over a few weeks to a few months, depending on baseline anemia and other treatments.
• Compared with other phosphate binders (such as calcium-based binders or sevelamer), ferric citrate lowers phosphate to a similar degree but also increases iron stores, which can reduce or delay the need for IV iron in some patients.
• Unlike calcium-based binders, it does not add extra calcium, which may be advantageous in patients at risk for high blood calcium or vascular calcification, but it can increase body iron and requires monitoring of iron parameters.

Typical adult dosing

• Each tablet contains 210 mg ferric iron (equivalent to 1 g ferric citrate).
• For high phosphorus in CKD on dialysis: initial dose is usually 2 tablets by mouth three times daily with meals; the dose is adjusted in steps of 1–2 tablets per day at weekly or longer intervals to reach target serum phosphorus, up to a maximum of 12 tablets per day.
• For iron deficiency anemia in CKD not on dialysis: initial dose is usually 1 tablet by mouth three times daily with meals; the dose is adjusted as needed to reach and maintain hemoglobin goals, up to 12 tablets per day.

How to take it

• Take with meals to bind dietary phosphate and improve tolerability.
• Swallow tablets whole with water; do not crush, chew, or break, as this can stain the mouth and teeth and may affect release.
• If you take other oral medicines that might interact (for example, medicines whose absorption is reduced by iron), your clinician may advise separating their dosing time from ferric citrate.

Special dosing instructions

• Therapy is individualized based on blood phosphorus, hemoglobin, ferritin, and transferrin saturation results.
• Iron parameters should be checked periodically; doses of IV iron or other iron supplements may need to be reduced or stopped once ferric citrate is started.

Missed dose

• If a dose is missed, skip it and take the next dose at the usual time with your next meal.
• Do not take two doses at once to make up for a missed dose.

Overdose

• In adults, taking too many tablets can cause significant gastrointestinal symptoms and potentially iron overload; seek medical advice or contact poison control right away.
• In children, accidental ingestion is an emergency—call emergency services or poison control immediately and bring the medication container with you.

Common side effects

• Very common: diarrhea, constipation, nausea, vomiting, and discolored or dark stools; abdominal pain and cough also occur in some patients.
• In patients treated for anemia, high blood potassium (hyperkalemia) has been reported in a minority of patients with CKD not on dialysis.
• These effects usually start in the first days to weeks of treatment and are often mild to moderate, but bothersome or persistent symptoms should be discussed with a clinician.

Serious or rare adverse effects

• Iron overload (too much iron), especially if used with other iron products or in patients who already have high ferritin or transferrin saturation.
• Severe gastrointestinal symptoms (persistent vomiting, severe abdominal pain, or signs of bowel obstruction) or severe allergic reactions (rash, swelling of face/lips/tongue, trouble breathing) require immediate medical attention.
• Accidental overdose in children can cause life-threatening iron poisoning and is a medical emergency.

Warnings and precautions

• Contraindicated in patients with iron overload syndromes such as hemochromatosis.
• Use in pregnancy or breastfeeding only if the potential benefit justifies the potential risk; data in humans are limited, and excessive iron exposure may be harmful.
• Safety and effectiveness have not been established in patients under 18 years of age.
• In CKD, no formal dose adjustment is recommended beyond usual titration, but iron stores (ferritin, transferrin saturation) and phosphorus should be monitored regularly.
• Use with caution in patients with significant gastrointestinal disease, where diarrhea or constipation could worsen symptoms.

Safety compared with other options

• Does not contain calcium or aluminum, avoiding risks of aluminum accumulation and excess calcium load seen with some other binders.
• However, it can raise iron stores, which is beneficial for anemia but increases the risk of iron overload if not monitored.

Reporting and staying updated

• Patients and caregivers can report side effects to the FDA MedWatch program (online or at 1-800-FDA-1088) or to the product manufacturer.
• Healthcare professionals should consult the current prescribing information and FDA safety communications for the latest warnings and updates.

Drug and supplement interactions

• Ferric citrate can bind to some oral medications in the gut, reducing their absorption (for example, certain antibiotics, thyroid medicines, or other drugs that interact with polyvalent cations); your clinician may recommend taking these at a different time.
• Using other iron-containing products (oral or IV) together with ferric citrate increases the risk of iron overload and usually requires closer monitoring and possible dose reduction of the other iron therapy.
• Antacids or acid-suppressing drugs are not strictly contraindicated but may alter the intestinal environment; dosing plans should be individualized by the prescriber.
• Multivitamins or supplements that contain iron should generally be avoided unless specifically recommended.

Food, alcohol, and testing interactions

• Should always be taken with meals for best effect on phosphate binding.
• Alcohol has no known direct interaction with ferric citrate, but both alcohol and advanced CKD can affect the stomach, liver, and overall health, so alcohol use should be discussed with the care team.
• Iron can darken stools and may make interpretation of some stool-based tests (for example, tests for hidden blood) more difficult; inform your clinician and laboratory if you are taking ferric citrate.

Conditions and co-medications requiring caution

• Do not use in patients with known iron overload syndromes, such as hereditary hemochromatosis.
• Use with caution in patients who already have high ferritin or transferrin saturation, or who receive regular blood transfusions or high-dose IV iron.
• Patients with significant gastrointestinal disease (e.g., inflammatory bowel disease, severe chronic diarrhea or constipation) may be more sensitive to GI side effects.
• In pregnancy or breastfeeding, use only after careful discussion of risks and benefits; monitor for iron overload if used long term.

Monitoring needs

• Serum phosphorus (for patients on dialysis using ferric citrate as a phosphate binder).
• Hemoglobin, ferritin, and transferrin saturation to track anemia treatment and avoid iron overload.
• Serum potassium in CKD patients, especially those treated for anemia who are at risk for hyperkalemia.
• Periodic review of all medications and supplements to adjust timing or dosing and minimize interactions.

Q: What is ferric citrate used for?
A: Ferric citrate is used in adults with chronic kidney disease to lower high blood phosphorus when on dialysis and to treat iron deficiency anemia when not on dialysis.

Q: How long does it take for ferric citrate to start working?
A: Phosphorus levels often begin to improve within 1–2 weeks, while increases in hemoglobin and iron stores usually occur over several weeks to a few months.

Q: Can I crush or chew ferric citrate tablets?
A: No, tablets should be swallowed whole with water, because crushing or chewing can stain the mouth and teeth and may change how the medicine works.

Q: Will ferric citrate change the color of my stool?
A: Yes, dark or discolored stools are common with iron-containing medicines like ferric citrate and are usually not harmful, but you should report any tarry or bloody stools to your clinician.

Q: What should I do if I miss a dose?
A: If you miss a dose, skip it and take your next scheduled dose with your next meal; do not double up to make up for the missed dose.

Q: Is ferric citrate safe during pregnancy or breastfeeding?
A: There is limited information in pregnant or breastfeeding women, so it should be used only if clearly needed and under close medical supervision, with attention to avoiding excessive iron levels.

Storage

• Store at room temperature (about 68°–77°F / 20°–25°C) in a dry place.
• Keep tablets in the original, tightly closed container and protect from moisture.
• Keep out of the reach of children, as accidental iron overdose can be very dangerous.

Disposal

• If you no longer need the medicine or it is expired, use a drug take-back program if available in your community.
• If no take-back option is available, follow pharmacist or local guidance; do not crush tablets and do not flush them unless specifically instructed.
• Keep tablets secured until disposal to prevent accidental ingestion by children or pets.